The International Master of Science in Paediatric Medicines Development and Evaluation awarded by the University of Rome “Tor Vergata” School of Paediatrics in collaboration with the Children’s Hospital Bambino Gesù and the EU Project Global Research in Paediatrics...
In October 2014, the European Medicines Agency (EMA) Board adopted the wording of the Agency’s new policy intended to further increase the availability of clinical trials data for medicinal products authorised in the EU: European Medicines Agency policy on publication...
Registrations are now open for the International Master of Science in Paediatric Medicines Development and Evaluation awarded by the University of Rome “Tor Vergata” School of Paediatrics in collaboration with the Children’s Hospital Bambino Gesù and the EU Project...
CVBF, partner of Fondazione Gianni Benzi and the paediatric clinical research activities carried out through its DEEP project have been the object of an article published on “Il sole 24 ore – Eventi Sud” on 20th October with the title “CVBF – Innovazione nella ricerca...
Another important step has been made this month for people living with rare diseases in Europe! After years of front line advocacy by EURORDIS, the European Committee of Experts on Rare Diseases (EUCERD) has adopted its recommendation to the European Commission and...
The annual report on the State of the Art of Rare Disease Activities in Europe is now available online. This extensive report provides a comprehensive overview of rare disease and orphan drug activities at both the European Union (EU) and Member State levels...
Following the positive evaluation of the Scientific Committee, the Gianni Benzi Pharmacological Research Foundation awarded a research grant for a project entitled “Endothelial function and cardiovascular risk in a cohort of haemophilic children”. The research will...
A Conference on European Reference Networks (ERNs) was held on 23rd June 2014 in Brussels to discuss the organisation of specialised networks across the EU and examine the next steps of the deployment process, in preparation of the forthcoming call for European...
The 2013 report, "The use of drugs in Italy", of the National Observatory on the Use of Medicines (OsMed) has been recently published. The work, realised by the Italian Medicine Agency (AIFA) photographs the state of health of the population, providing a very detailed...
On the 12th of June 2014, the European Medicines Agency (EMA) Management Board agreed the policy on publication of clinical trial data, that will be effective from the 1st of October 2014. It has been developed following the broadest possible consensus among its...
Recent posts in News